Medtronic's latest regulatory wins further support its fast-growing arrhythmia-treating cardiac ablation business.

As Boston Scientific, Medtronic, Abbott, and J&J battle for PFA market share, Pulse Biosciences could rewrite the competitive ...

U.S. Pulsed Field Ablation Catheters Market to Reach USD 5.15 Billion and Europe USD 4.06 Billion by 2035 as Rising AFib ...

The regulatory authorizations come as Medtronic looks to differentiate itself in the fast-growing pulsed field ablation ...

Medtronic has raised its dividend for 49 straight years while the stock quietly lost a fifth of its value, but something in ...

Please provide your email address to receive an email when new articles are posted on . In patients with atrial fibrillation, catheter ablation reduces anxiety and depression symptoms better than ...

The new regulatory approvals expand Medtronic’s mapping and tissue-proximity capabilities for cardiac ablation.

Despite having an implantable cardioverter-defibrillator, a 62-year-old woman suffered from ongoing atrial fibrillation and ...

Patients with structural heart disease are at risk for life-threatening ventricular tachycardias (VTs). Implantable cardioverter-defibrillators (ICDs) can terminate VT, but often at the cost of ...

Compared with medical therapy, rhythm control with catheter ablation is associated with lower risk of ischemic stroke after 30 days, as well as less mortality and heart failure (HF) hospitalization, ...

Cardiac arrhythmias are a leading cause of morbidity and mortality worldwide. Catheter ablation provides a minimally invasive means to target and eliminate arrhythmogenic substrates within the heart.

Share on Pinterest First cryoablation surgery performed at Zakarpattia Regional Cardiology Centre UZHHOROD, UKRAINE – FEBRUARY 3, 2020 – Professor of the Gottsegen Hungarian Institute of Cardiology ...